Researchers at Rutgers Robert Wood Johnson Medical School have reported the first instance of COVID-19 triggering a recurrence of Guillain–Barré Syndrome – a rare disorder where the body’s immune system attacks nerves and can lead to respiratory failure and death. While there have been several reports of Guillain–Barré Syndrome following COVID-19, this is the first in which COVID-19 actually triggered a recurrence of the condition – in a 54-year-old man who had suffered with Guillain–Barré Syndrome twice and had a third occurrence after testing positive for COVID-19, according to the Rutgers case report published in the journal Pathogens. To read the full story.
Home / News / Rutgers Reports First Instance of COVID-19 Triggering Recurrent Guillain-Barré Syndrome
Recent Posts
- Ozempic in a Pill? It’s Closer Than You Think.
- NJIT Students Develop Mental Health Side-Effect Tracker Recognized at Pfizer Hackathon.
- Older Adults With HIV May Be Facing Unequal Burden in the Opioid Crisis.
- Rutgers Medical Students Learn Importance of Humanity, Creativity and Connection in Patient-Centered Medicine.
- Artificial Intelligence Recreates the Motion of a Beating Heart Using Surface Electrical Recordings.
Categories
- Community (2,365)
- Covid (992)
- CTO Events (6)
- News (3,002)
- Pilots (21)